278 related articles for article (PubMed ID: 31675930)
1. Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin.
Bolandghamat Pour Z; Nourbakhsh M; Mousavizadeh K; Madjd Z; Ghorbanhosseini SS; Abdolvahabi Z; Hesari Z; Ezzati Mobasser S
BMC Cancer; 2019 Nov; 19(1):1027. PubMed ID: 31675930
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
Hesari Z; Nourbakhsh M; Hosseinkhani S; Abdolvahabi Z; Alipour M; Tavakoli-Yaraki M; Ghorbanhosseini SS; Yousefi Z; Jafarzadeh M; Yarahmadi S
Gene; 2018 Oct; 673():149-158. PubMed ID: 29886033
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26b Reduces Cell Viability by Inhibition of Nicotinamide Phosphoribosyltransferase in Breast Cancer Cells.
Ameli Mojarad M; Ameli Mojarad M; Pourmahdian A
DNA Cell Biol; 2022 Aug; 41(8):735-741. PubMed ID: 35792597
[TBL] [Abstract][Full Text] [Related]
4. MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD.
Alizadeh-Fanalou S; Hosseinkhani S; Nazarizadeh A; Ezzati-Mobaser S; Hesari Z; Aziminezhadan P; Abdolvahabi Z; Abolmaali M; Tavakoli-Yaraki M; Nourbakhsh M
DNA Cell Biol; 2021 Jul; 40(7):1026-1036. PubMed ID: 34101492
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of miR-381 inhibits NAD+ salvage pathway and promotes apoptosis in breast cancer cells.
Bolandghamat Pour Z; Nourbakhsh M; Mousavizadeh K; Madjd Z; Ghorbanhosseini SS; Abdolvahabi Z; Hesari Z; Mobaser SE
EXCLI J; 2019; 18():683-696. PubMed ID: 31611752
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 induces breast cancer cell apoptosis and reduces cell viability by inhibition of nicotinamide phosphoribosyltransferase expression and activity.
Ghorbanhosseini SS; Nourbakhsh M; Zangooei M; Abdolvahabi Z; Bolandghamtpour Z; Hesari Z; Yousefi Z; Panahi G; Meshkani R
EXCLI J; 2019; 18():838-851. PubMed ID: 31645844
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide phosphoribosyl transferase (Nampt) is a target of microRNA-26b in colorectal cancer cells.
Zhang C; Tong J; Huang G
PLoS One; 2013; 8(7):e69963. PubMed ID: 23922874
[TBL] [Abstract][Full Text] [Related]
8. The NAD(+) salvage pathway modulates cancer cell viability via p73.
Sharif T; Ahn DG; Liu RZ; Pringle E; Martell E; Dai C; Nunokawa A; Kwak M; Clements D; Murphy JP; Dean C; Marcato P; McCormick C; Godbout R; Gujar SA; Lee PW
Cell Death Differ; 2016 Apr; 23(4):669-80. PubMed ID: 26586573
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
Yarahmadi S; Abdolvahabi Z; Hesari Z; Tavakoli-Yaraki M; Yousefi Z; Seiri P; Hosseinkhani S; Nourbakhsh M
Gene; 2019 Aug; 711():143939. PubMed ID: 31220581
[TBL] [Abstract][Full Text] [Related]
10. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.
Choi SE; Fu T; Seok S; Kim DH; Yu E; Lee KW; Kang Y; Li X; Kemper B; Kemper JK
Aging Cell; 2013 Dec; 12(6):1062-72. PubMed ID: 23834033
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
12. miR-146a impedes the anti-aging effect of AMPK via NAMPT suppression and NAD
Gong H; Chen H; Xiao P; Huang N; Han X; Zhang J; Yang Y; Li T; Zhao T; Tai H; Xu W; Zhang G; Gong C; Yang M; Tang X; Xiao H
Signal Transduct Target Ther; 2022 Mar; 7(1):66. PubMed ID: 35241643
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
[TBL] [Abstract][Full Text] [Related]
14. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.
Sociali G; Grozio A; Caffa I; Schuster S; Becherini P; Damonte P; Sturla L; Fresia C; Passalacqua M; Mazzola F; Raffaelli N; Garten A; Kiess W; Cea M; Nencioni A; Bruzzone S
FASEB J; 2019 Mar; 33(3):3704-3717. PubMed ID: 30514106
[TBL] [Abstract][Full Text] [Related]
15. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
Moazzeni H; Najafi A; Khani M
Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
[TBL] [Abstract][Full Text] [Related]
16. NAMPT regulates PKM2 nuclear location through 14-3-3ζ: Conferring resistance to tamoxifen in breast cancer.
Ge X; Zhao Y; Dong L; Seng J; Zhang X; Dou D
J Cell Physiol; 2019 Dec; 234(12):23409-23420. PubMed ID: 31141164
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer.
Santidrian AF; LeBoeuf SE; Wold ED; Ritland M; Forsyth JS; Felding BH
DNA Repair (Amst); 2014 Nov; 23():79-87. PubMed ID: 25263164
[TBL] [Abstract][Full Text] [Related]
19. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
